Skip to content
★ Sign in to follow
PB

Peter B. Davis

Vaxart, Inc.
Total declarations
5
Company
1
▲ Purchases (3 ops.)
€26k
▼ Sales (0 ops.)
—

Latest filing published 24 May 2010 for Vaxart, Inc., €16k.

Insider track record

Disclosed buys
3
Disclosed sells
0
Signal history

No signal scores available.

Closed purchases

Market purchases
3
Positive at T+90
67%
Median T+90
+10.1%

Based on 3 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.

Purchases by company

Since each purchase

  • Filed 24 May 2010 · 6013 days ago · €16k
    +1.7%
    Entry US$353.10 · Close at T+365 US$359.04
  • Filed 25 Nov 2009 · 6193 days ago · €2,663
    +4.5%
    Entry US$319.44 · Close at T+365 US$333.96

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Peter B. Davis: trading record in brief

Peter B. Davis appears in our data through filings on Vaxart, Inc. shares, published by SEC (Form 4). In total, 5 filings cover trades dated from 12 May 2006 to 20 May 2010.

No open-market sale appears; the market trades are 3 purchases worth €26k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 2 share grants. Since January 2010: 1 purchase and no sales on the market.

Half of the purchases are above €7,323 and half below. Ninety days after publication, 3 purchases show a median change of +10.1%, with the price up in 67% of them. Past outcomes like these are no guarantee of what comes next.

On 24 May 2010 came the latest disclosure, an open-market purchase for €16k in Vaxart, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Companies and markets linked to Peter B. Davis

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations5 total
  • ▲
    DirectorExecutivesVaxart, Inc.
    19,996 USD0SEC
    3,816 shares@ US$5.24Common StockSEC:0001491877-10-000007:0
    Canonical exit: 18 Aug 2010 (T+90)
  • ▲
    DirectorExecutivesVaxart, Inc.
    3,984 USD0SEC
    800 shares@ US$4.98Common stockSEC:0001455244-09-000130:0
    Canonical exit: 21 Feb 2010 (T+90)
  • ▲
    DirectorExecutivesVaxart, Inc.
    10,956 USD0SEC
    2,200 shares@ US$4.98Common stockSEC:0001455244-09-000130:1
    Canonical exit: 21 Feb 2010 (T+90)
  • ◆
    DirectorExecutivesVaxart, Inc.
    0SEC
    3,846 shares0Common StockSEC:0001373185-07-000015:0
  • ◆
    DirectorExecutivesVaxart, Inc.
    24,998 USD0SEC
    3,968 shares@ US$6.30Common StockSEC:0001278819-06-000014:0

5 of 5 declarations